🇺🇸 PACLITAXEL in United States

42,654 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 5,350 reports (12.54%)
  2. Nausea — 5,021 reports (11.77%)
  3. Neutropenia — 4,817 reports (11.29%)
  4. Off Label Use — 4,615 reports (10.82%)
  5. Diarrhoea — 4,559 reports (10.69%)
  6. Anaemia — 4,121 reports (9.66%)
  7. Malignant Neoplasm Progression — 3,746 reports (8.78%)
  8. Fatigue — 3,540 reports (8.3%)
  9. Disease Progression — 3,469 reports (8.13%)
  10. Vomiting — 3,416 reports (8.01%)

Source database →

PACLITAXEL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PACLITAXEL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PACLITAXEL in United States?

Marketing authorisation holder not available in our data.